Evaluation and Comparison of the Predictive Value of 4C Mortality Score, NEWS, and CURB-65 in Poor Outcomes in COVID-19 Patients: A Retrospective Study from a Single Center in Romania.
4C Mortality
COVID-19
CURB-65
NEWS
mortality
prediction
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
13 Mar 2022
13 Mar 2022
Historique:
received:
21
02
2022
revised:
09
03
2022
accepted:
10
03
2022
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
26
3
2022
Statut:
epublish
Résumé
To date, the COVID-19 pandemic has caused millions of deaths across the world. Prognostic scores can improve the clinical management of COVID-19 diagnosis and treatment. The objective of this study was to assess the predictive role of 4C Mortality, CURB-65, and NEWS in COVID-19 mortality among the Romanian population. A single-center, retrospective, observational study was conducted on patients with reverse transcriptase-polymerase chain reaction (RT-PCR)-proven COVID-19 admitted to the Municipal Emergency Clinical Hospital of Timisoara, Romania, between 1 October 2020 and 15 March 2021. Receiver operating characteristic (ROC) and area under the curve (AUC) analyses were performed to determine the discrimination accuracy of the three scores. The mean values of the risk scores were higher in the non-survivors group (survivors group vs. non-survivors group: 8 vs. 15 (4C Mortality Score); 3 vs. 8.5 (NEWS); 1 vs. 3 (CURB-65)). In terms of mortality risk prediction, the NEWS performed best, with an AUC of 0.86, and the CURB-65 score performed poorly, with an AUC of 0.80. CURB-65, NEWS, and 4C Mortality scores were significant mortality predictors in the analysis, with acceptable calibration. Among the scores assessed in our study, NEWS had the highest performance in predicting in-hospital mortality in COVID-19 patients. Thus, the findings from this study suggest that the use of NEWS may be beneficial to the early identification of high-risk COVID-19 patients and the provision of more aggressive care to reduce mortality associated with COVID-19.
Identifiants
pubmed: 35328256
pii: diagnostics12030703
doi: 10.3390/diagnostics12030703
pmc: PMC8947715
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Int J Clin Pract. 2021 Oct;75(10):e14759
pubmed: 34455674
Epidemiol Infect. 2020 Oct 01;148:e241
pubmed: 32998791
BMJ Open. 2021 Sep 8;11(9):e052708
pubmed: 34497086
IEEE Access. 2020 Jun 12;8:109581-109595
pubmed: 34192103
Resuscitation. 2021 Feb;159:150-157
pubmed: 33176170
BMJ. 2020 Sep 9;370:m3339
pubmed: 32907855
Ann Med. 2021 Dec;53(1):402-409
pubmed: 33629918
Int J Clin Pract. 2021 Mar;75(3):e13926
pubmed: 33296132
J Infect. 2020 Sep;81(3):e96-e98
pubmed: 32474039
Thorax. 2003 May;58(5):377-82
pubmed: 12728155
Diagnostics (Basel). 2022 Jan 06;12(1):
pubmed: 35054289
Ann Epidemiol. 2021 May;57:14-21
pubmed: 33662494
Int J Clin Pract. 2021 Jun;75(6):e14121
pubmed: 33650136
Intensive Care Med. 2021 Dec;47(12):1426-1439
pubmed: 34585270
Clin Med (Lond). 2020 Jul;20(4):e133-e134
pubmed: 32675168
Acta Biomed. 2020 Mar 19;91(1):157-160
pubmed: 32191675
Thorax. 2020 Nov;75(11):1009-1016
pubmed: 32839287
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632